Search reports.
Postpartum Depression Market Share, Growth & Forecast [2031]
Get free sample report Request for Customiztion Buy Now

Postpartum Depression Market Share, Growth & Forecast [2031]

Segments - Postpartum Depression Market by Types (Postpartum Anxiety, Postpartum Blues, Postpartum Panic Disorder, Postpartum Obsessive-Compulsive Disorder, Postpartum Psychosis, and Others), Treatments (Medication, Psychotherapy, Electroconvulsive Therapy (ECT), Supplements, and Others), Routes of Administration (Parenteral, Oral, and Others), End-users (Specialty Clinics, Hospitals, Homecare, and Others), Distribution Channels (Online and Offline), and Regions (Asia Pacific, North America, Latin America, Europe and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-4187 | 4.1 Rating | 76 Reviews | 167 Pages | Format : PDF Excel PPT

Report Description


The global postpartum depression market size was valued at around USD 5.11 billion in 2021 and is anticipated to reach USD 42.37 billion by 2030, expanding at a CAGR of around 30% during the forecast period, 2022 – 2030. The growth of the market is attributed to the rising awareness of postpartum depression and increasing healthcare expenditure across the globe.

Global Postpartum Depression Market Outlook

Postpartum refers to the time after childbirth. It starts immediately after delivery as the body of a mother, including uterus size and hormones, returns to its non-pregnant state. Postpartum depression is a form of major depression experienced by a mother after childbirth. It arises from the combination of fatigue, hormonal changes, and psychological adjustment to motherhood. Postpartum depression usually begins within four weeks after childbirth.

Most new mothers experience postpartum blues or baby blues after delivery. It includes crying spells, mood swings, anxiety, and difficulty in sleeping. Postpartum blues mostly begin within first three days after delivery, and they may last up to two weeks. Some new mothers, however, suffer from more sever and long-lasting form of depression than the postpartum blues. Some of the postpartum depression signs and symptoms include severe mood swings, excessive crying, difficulty in bonding with the baby, loss of appetite, social withdrawal, insomnia, panic attacks, and others. Severe form of postpartum depression is known as postpartum psychosis, which is recognized with its symptoms such as disorientation, confusion, obsessive thoughts regarding the baby, hallucinations, delusions, paranoia, self-harm, and others.

Women are advised to visit doctors if the postpartum depression symptoms are prolonged. Therapies, medications, rest, and sharing the experiences can aid in tackling postpartum depression.

  • Increasing incidents of mood disorders among women are expected to drive the market during the forecast period.
  • Rising healthcare expenditure to improve its infrastructure across the globe is estimated to boost the market in the coming years.
  • High alcohol consumption and rapidly changing lifestyle fuel the market.
  • Increasing initiatives of private and public organizations regarding postpartum depression are projected to expand the market during the forecast period.
  • Growing demand for antidepressant medications and rising need of therapists spur the market.
  • Technological advancements drive the postpartum depression market.
  • High cost of medication is anticipated to hamper the growth of the market in the coming years.
  • Lack of awareness regarding postpartum depression and dearth of healthcare infrastructure in developing countries are expected to hinder the growth of the market during the projected period.
  • Increasing number of research & development activities offer growth opportunities to the key market players.
  • Rising number of drug approvals offer lucrative growth opportunities to the key market players in the coming years.

Scope of the Report

The report on the global postpartum depression market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

Postpartum Depression Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2021

Historic Data

2019–2020

Forecast Period

2022–2030

Segmentation

Types (Postpartum Anxiety, Postpartum Blues, Postpartum Panic Disorder, Postpartum Obsessive-Compulsive Disorder, Postpartum Psychosis, and Others), Treatments (Medication, Psychotherapy, Electroconvulsive Therapy (ECT), Supplements, and Others), Routes of Administration (Parenteral, Oral, and Others), End-users (Specialty Clinics, Hospitals, Homecare, and Others), and Distribution Channels (Online and Offline)

Regional Scope

Asia Pacific, North America, Latin America, Europe, and Middle East & Africa

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Pfizer, Inc.; Sage Therapeutics, Inc.; Allergan, Inc.; Biogen, Inc.; Eli Lily and Company; Geisinger Health System; Sebela Pharmaceuticals, Inc.; Mylan N. V.; Johnson & Johnson Private Limited; Teva Pharmaceuticals Industries, Ltd.; GSK Group of Companies; Novartis International AG; Sanofi S. A.; Bayer AG; Lupin Limited; Sun Pharmaceuticals Industries, Ltd.; Cipla, Inc.; SHIONOGI & Co., Ltd.; and Others

Market Segment Insights

Postpartum blues segment drives the market

In terms of types, the market is divided into postpartum anxiety, postpartum blues, postpartum panic disorder, postpartum obsessive-compulsive disorder, postpartum psychosis, and others. the postpartum blues segment is expected to boost the market during the forecast period, as it is estimated that the postpartum blues affect most of the women after delivery across the globe.

Global Postpartum Depression Market by Types

Medication segment expands rapidly

On the basis of treatments, the market is segregated into medication, psychotherapy, electroconvulsive therapy (ECT), supplements, and others. The medication segment is expected to boost the market during the forecast period, owing to increasing launches of innovative and branded drugs. High availability of medicines and drugs in the form of tablets, capsules, injections, and others is anticipated to boost the expansion of the medication segment in the coming years. Increasing focus on non-medication treatment options such as psychotherapy is expected to expand of psychotherapy segment during the forecast period.

Global Postpartum Depression Market by Treatments

Oral segment boosts the market

Based on routes of administration, the market is divided into parenteral, oral, and others. The oral segment is estimated to drive the market during the forecast period, due to high availability of orally administered drugs in forms of tablets, capsules, and other oral solutions.

Specialty clinics segment fuels the market

In terms of end-users, the market is segmented into specialty clinics, hospitals, homecare, and others. The specialty clinics segment is anticipated to expand at a significant pace during the forecast period, due to high-quality treatment and resources provided by the clinics. Specialty clinics facilitate patients in early detection, prevention, elimination, and cure for postpartum depression, which aid in the expansion of the segment.

Offline segment holds a key market share

On the basis of distribution channels, the market is bifurcated into online and offline. The offline segment is projected to fuel the market during the forecast period, as consumers prefer to buy prescribed drugs from offline distribution channels such as hospital pharmacies. These pharmacies are attached to hospitals; therefore, they usually have all the medicines and drugs prescribed by doctors. The online segment is anticipated to expand during the forecast period, due to increasing usage of internet, growing availability of smart devices, and rising number of online pharmacies.

North America dominates the market

In terms of regions, the market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is projected to register a high CAGR during the forecast period, owing to rising prevalence of postpartum depression among women in the region. Growing number of major key players in the region is estimated to spur the growth of the market in North America. Rising government initiatives and developing health infrastructure are anticipated to expand the market in Asia Pacific in the coming years.

Global Postpartum Depression Market by Regions

Segments

The global postpartum depression market has been segmented on the basis of

Types
  • Postpartum Anxiety
  • Postpartum Blues
  • Postpartum Panic Disorder
  • Postpartum Obsessive-Compulsive Disorder
  • Postpartum Psychosis
  • Others
Treatments
  • Medication
  • Psychotherapy
  • Electroconvulsive Therapy (ECT)
  • Supplements
  • Others
Routes of Administration
  • Parenteral
  • Oral
  • Others
End-users
  • Specialty Clinics
  • Hospitals
  • Homecare
  • Others
Distribution Channels
  • Online
  • Offline
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Pfizer, Inc.
  • Sage Therapeutics, Inc.
  • Allergan, Inc.
  • Biogen, Inc.
  • Eli Lily and Company
  • Geisinger Health System
  • Sebela Pharmaceuticals, Inc.
  • Mylan N. V.
  • Johnson & Johnson Private Limited
  • Teva Pharmaceuticals Industries, Ltd.
  • GSK Group of Companies
  • Novartis International AG
  • Sanofi S. A.
  • Bayer AG
  • Lupin Limited
  • Sun Pharmaceuticals Industries, Ltd.
  • Cipla, Inc.
  • SHIONOGI & Co., Ltd.
  • Others

Competitive Landscape

The global postpartum depression market is competitive with the presence of key players such as Pfizer, Inc.; Sage Therapeutics, Inc.; Allergan, Inc.; Biogen, Inc.; Eli Lily and Company; Geisinger Health System; Sebela Pharmaceuticals, Inc.; Mylan N. V.; Johnson & Johnson Private Limited; Teva Pharmaceuticals Industries, Ltd.; GSK Group of Companies; Novartis International AG; Sanofi S. A.; Bayer AG; Lupin Limited; Sun Pharmaceuticals Industries, Ltd.; Cipla, Inc.; SHIONOGI & Co., Ltd.; and others, who use strategies such as mergers, collaborations, acquisitions, product launches, and partnerships to strengthen their hold on the market. For example, in November 2020, Sage Therapeutics, Inc. collaborated with Biogen, Inc. to develop and commercialize Zuranolone (SAGE-217), a drug for the treatment for major depressive disorder and postpartum depression. In May 2020, Geisinger Health System, a healthcare provider, announced the launch of an innovative postpartum screening program. It aims at providing a standardized postpartum depression screening through pregnancy journey of women.

Global Postpartum Depression by Key Players

Frequently Asked Questions

Pfizer, Inc.; Sage Therapeutics, Inc.; Allergan, Inc.; Biogen, Inc.; Eli Lily and Company; Geisinger Health System; Sebela Pharmaceuticals, Inc.; Mylan N. V.; Johnson & Johnson Private Limited; and Teva Pharmaceuticals Industries, Ltd. are some of the key market players.

North America dominates the global postpartum depression market.

Postpartum depression is a form of major depression experienced by a mother after childbirth.

Postpartum blues, postpartum panic disorder, postpartum obsessive-compulsive disorder, postpartum psychosis, and others are the types of postpartum depression.

The global postpartum depression market size was valued at around USD 5.11 billion in 2021.

The global postpartum depression market is estimated to register CAGR of around 30% during the forecast period.

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Postpartum Depression Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Postpartum Depression Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Postpartum Depression Market - Supply Chain
  4.5. Global Postpartum Depression Market Forecast
     4.5.1. Postpartum Depression Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Postpartum Depression Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Postpartum Depression Market Absolute $ Opportunity
5. Global Postpartum Depression Market Analysis and Forecast by Types
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Types
     5.2.2. Y-o-Y Growth Projections by Types
  5.3. Postpartum Depression Market Size and Volume Forecast by Types
     5.3.1. Postpartum Anxiety
     5.3.2. Postpartum Blues
     5.3.3. Postpartum Panic Disorder
     5.3.4. Postpartum Obsessive-Compulsive Disorder
     5.3.5. Postpartum Psychosis
     5.3.6. Others
  5.4. Absolute $ Opportunity Assessment by Types
  5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Postpartum Depression Market Analysis and Forecast by End Users
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by End Users
     6.2.2. Y-o-Y Growth Projections by End Users
  6.3. Postpartum Depression Market Size and Volume Forecast by End Users
     6.3.1. Specialty Clinics
     6.3.2. Hospitals
     6.3.3. Homecare
     6.3.4. Others
  6.4. Absolute $ Opportunity Assessment by End Users
  6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Postpartum Depression Market Analysis and Forecast by Region
  7.1. Market Trends
  7.2. Introduction
     7.2.1. Basis Point Share (BPS) Analysis by Region
     7.2.2. Y-o-Y Growth Projections by Region
  7.3. Postpartum Depression Market Size and Volume Forecast by Region
     7.3.1. North America
     7.3.2. Latin America
     7.3.3. Europe
     7.3.4. Asia Pacific
     7.3.5. Middle East and Africa (MEA)
  7.4. Absolute $ Opportunity Assessment by Region
  7.5. Market Attractiveness/Growth Potential Analysis by Region
  7.6. Global Postpartum Depression Demand Share Forecast, 2019-2026
8. North America Postpartum Depression Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
  8.2. North America Postpartum Depression Market Size and Volume Forecast by Country
     8.2.1. U.S.
     8.2.2. Canada
  8.3. Absolute $ Opportunity Assessment by Country
  8.4. North America Postpartum Depression Market Size and Volume Forecast by Types
     8.4.1. Postpartum Anxiety
     8.4.2. Postpartum Blues
     8.4.3. Postpartum Panic Disorder
     8.4.4. Postpartum Obsessive-Compulsive Disorder
     8.4.5. Postpartum Psychosis
     8.4.6. Others
  8.5. Basis Point Share (BPS) Analysis by Types
  8.6. Y-o-Y Growth Projections by Types
  8.7. North America Postpartum Depression Market Size and Volume Forecast by End Users
     8.7.1. Specialty Clinics
     8.7.2. Hospitals
     8.7.3. Homecare
     8.7.4. Others
  8.8. Basis Point Share (BPS) Analysis by End Users
  8.9. Y-o-Y Growth Projections by End Users
  8.10. Market Attractiveness/Growth Potential Analysis
     8.10.1. By Country
     8.10.2. By Product Type
     8.10.3. By Application
  8.11. North America Postpartum Depression Demand Share Forecast, 2019-2026
9. Latin America Postpartum Depression Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Latin America Average Pricing Analysis
  9.2. Latin America Postpartum Depression Market Size and Volume Forecast by Country
      9.2.1. Brazil
      9.2.2. Mexico
      9.2.3. Rest of Latin America
   9.3. Absolute $ Opportunity Assessment by Country
  9.4. Latin America Postpartum Depression Market Size and Volume Forecast by Types
     9.4.1. Postpartum Anxiety
     9.4.2. Postpartum Blues
     9.4.3. Postpartum Panic Disorder
     9.4.4. Postpartum Obsessive-Compulsive Disorder
     9.4.5. Postpartum Psychosis
     9.4.6. Others
  9.5. Basis Point Share (BPS) Analysis by Types
  9.6. Y-o-Y Growth Projections by Types
  9.7. Latin America Postpartum Depression Market Size and Volume Forecast by End Users
     9.7.1. Specialty Clinics
     9.7.2. Hospitals
     9.7.3. Homecare
     9.7.4. Others
  9.8. Basis Point Share (BPS) Analysis by End Users
  9.9. Y-o-Y Growth Projections by End Users
  9.10. Market Attractiveness/Growth Potential Analysis
     9.10.1. By Country
     9.10.2. By Product Type
     9.10.3. By Application
  9.11. Latin America Postpartum Depression Demand Share Forecast, 2019-2026
10. Europe Postpartum Depression Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Europe Average Pricing Analysis
  10.2. Europe Postpartum Depression Market Size and Volume Forecast by Country
     10.2.1. Germany
     10.2.2. France
     10.2.3. Italy
     10.2.4. U.K.
     10.2.5. Spain
     10.2.6. Russia
     10.2.7. Rest of Europe
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Europe Postpartum Depression Market Size and Volume Forecast by Types
     10.4.1. Postpartum Anxiety
     10.4.2. Postpartum Blues
     10.4.3. Postpartum Panic Disorder
     10.4.4. Postpartum Obsessive-Compulsive Disorder
     10.4.5. Postpartum Psychosis
     10.4.6. Others
  10.5. Basis Point Share (BPS) Analysis by Types
  10.6. Y-o-Y Growth Projections by Types
  10.7. Europe Postpartum Depression Market Size and Volume Forecast by End Users
     10.7.1. Specialty Clinics
     10.7.2. Hospitals
     10.7.3. Homecare
     10.7.4. Others
  10.8. Basis Point Share (BPS) Analysis by End Users
  10.9. Y-o-Y Growth Projections by End Users
  10.10. Market Attractiveness/Growth Potential Analysis
     10.10.1. By Country
     10.10.2. By Product Type
     10.10.3. By Application
  10.11. Europe Postpartum Depression Demand Share Forecast, 2019-2026
11. Asia Pacific Postpartum Depression Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Asia Pacific Average Pricing Analysis
  11.2. Asia Pacific Postpartum Depression Market Size and Volume Forecast by Country
     11.2.1. China
     11.2.2. Japan
     11.2.3. South Korea
     11.2.4. India
     11.2.5. Australia
     11.2.6. Rest of Asia Pacific (APAC)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Asia Pacific Postpartum Depression Market Size and Volume Forecast by Types
     11.4.1. Postpartum Anxiety
     11.4.2. Postpartum Blues
     11.4.3. Postpartum Panic Disorder
     11.4.4. Postpartum Obsessive-Compulsive Disorder
     11.4.5. Postpartum Psychosis
     11.4.6. Others
  11.5. Basis Point Share (BPS) Analysis by Types
  11.6. Y-o-Y Growth Projections by Types
  11.7. Asia Pacific Postpartum Depression Market Size and Volume Forecast by End Users
     11.7.1. Specialty Clinics
     11.7.2. Hospitals
     11.7.3. Homecare
     11.7.4. Others
  11.8. Basis Point Share (BPS) Analysis by End Users
  11.9. Y-o-Y Growth Projections by End Users
  11.10. Market Attractiveness/Growth Potential Analysis
     11.10.1. By Country
     11.10.2. By Product Type
     11.10.3. By Application
  11.11. Asia Pacific Postpartum Depression Demand Share Forecast, 2019-2026
12. Middle East & Africa Postpartum Depression Market Analysis and Forecast
  12.1. Introduction
     12.1.1. Basis Point Share (BPS) Analysis by Country
     12.1.2. Y-o-Y Growth Projections by Country
     12.1.3. Middle East & Africa Average Pricing Analysis
  12.2. Middle East & Africa Postpartum Depression Market Size and Volume Forecast by Country
     12.2.1. Saudi Arabia
     12.2.2. South Africa
     12.2.3. UAE
     12.2.4. Rest of Middle East & Africa (MEA)
  12.3. Absolute $ Opportunity Assessment by Country
  12.4. Middle East & Africa Postpartum Depression Market Size and Volume Forecast by Types
     12.4.1. Postpartum Anxiety
     12.4.2. Postpartum Blues
     12.4.3. Postpartum Panic Disorder
     12.4.4. Postpartum Obsessive-Compulsive Disorder
     12.4.5. Postpartum Psychosis
     12.4.6. Others
  12.5. Basis Point Share (BPS) Analysis by Types
  12.6. Y-o-Y Growth Projections by Types
  12.7. Middle East & Africa Postpartum Depression Market Size and Volume Forecast by End Users
     12.7.1. Specialty Clinics
     12.7.2. Hospitals
     12.7.3. Homecare
     12.7.4. Others
  12.8. Basis Point Share (BPS) Analysis by End Users
  12.9. Y-o-Y Growth Projections by End Users
  12.10. Market Attractiveness/Growth Potential Analysis
     12.10.1. By Country
     12.10.2. By Product Type
     12.10.3. By Application
  12.11. Middle East & Africa Postpartum Depression Demand Share Forecast, 2019-2026
13. Competition Landscape
  13.1. Global Postpartum Depression Market: Market Share Analysis
  13.2. Postpartum Depression Distributors and Customers
  13.3. Postpartum Depression Market: Competitive Dashboard
  13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     13.4.1. Pfizer, Inc. Sage Therapeutics, Inc. Allergan, Inc. Biogen, Inc. Eli Lily and Company Geisinger Health System Sebela Pharmaceuticals, Inc. Mylan N. V. &am

Methodology

Our Clients

Deloitte
sinopec
Microsoft
General Electric
Siemens Healthcare
Honda Motor Co. Ltd.
Pfizer
General Mills